Sigachi Industries Ltd

Sigachi Industries, a small-cap player in the Pharmaceuticals & Biotechnology sector, has emerged as one of the most actively traded stocks by volume, reflecting heightened investor participation and notable price movement in recent sessions.

Sigachi Industries has exhibited a notable shift in its technical momentum, reflecting a complex interplay of bullish and bearish signals across multiple timeframes. The stock’s recent price action, combined with evolving technical indicators, offers a nuanced perspective on its near-term trajectory within the Pharmaceuticals & Biotechnology sector.

Sigachi Indust., a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a revision in its market evaluation reflecting recent financial and technical developments. This shift follows a detailed reassessment of the company’s quality, valuation, financial trends, and technical outlook, signalling a more cautious market perspective.

Sigachi Industries, a player in the Pharmaceuticals & Biotechnology sector, recorded one of the highest trading volumes on 28 Nov 2025, with over 2.2 crore shares exchanging hands. The stock demonstrated notable price volatility, touching an intraday high of ₹39.75, representing a 15.02% movement from its previous close, while trading within a wide range of ₹5.40 during the session.

Sigachi Industries recorded a robust intraday performance on 28 Nov 2025, touching a high of Rs 38.29, reflecting a notable surge of 11.02% during the trading session. The stock outpaced its sector and broader market indices, demonstrating significant volatility and active trading interest.

Sigachi Industries, a small-cap firm in the Pharmaceuticals & Biotechnology sector, has experienced a technical trend adjustment. The stock has faced a significant decline over the past year, underperforming compared to the Sensex. Various indicators suggest a bearish sentiment, despite some mixed performance signals in recent months.

Sigachi Industries, a small-cap firm in the Pharmaceuticals & Biotechnology sector, has experienced a 29.4% decline over the past year, contrasting with the Sensex's 5.09% return. Current trading shows mixed technical indicators, with a recent price range between 35.27 and 35.95, reflecting ongoing market challenges.

Sigachi Industries, a small-cap firm in the Pharmaceuticals & Biotechnology sector, has experienced a decline in stock price and mixed technical indicators. The company has faced significant challenges in returns compared to the Sensex over various timeframes, reflecting its struggles in the current market environment.

Sigachi Industries Ltd., a pharmaceutical excipients manufacturer with a market capitalisation of ₹1,458 crores, reported deeply troubling Q2 FY26 results that have sent alarm bells ringing across investor circles. The company posted a consolidated net profit of ₹10.69 crores for the quarter ended September 2025, marking a catastrophic 50.92% year-on-year decline and a staggering 110.65% quarter-on-quarter collapse from the previous quarter's exceptional loss of ₹100.35 crores.